STING1 and neoplasm: Recent efforts to remodel the TME using oncolytic viruses, transforming growth factor β (TGF-β), inhibitors, or stimulator of interferon genes (STING) agonists aim to overcome this suppression and reinvigorate anti-tumor immunity [17].